{"product_id":"icahn-school-of-medicine-myeloid-malignancy-workshop-2025","title":"Icahn School of Medicine Myeloid Malignancy Workshop 2025","description":"\u003cdiv class=\"grid-x grid-margin-x\"\u003e\r\n\u003cdiv class=\"cell initial-12 medium-8\"\u003e\r\n\u003ch1 class=\"product_title entry-title\"\u003eIcahn School of Medicine Myeloid Malignancy Workshop 2025\u003c\/h1\u003e\r\n\u003cstrong\u003e+ Include: 10 videos + 1 pdf, size: 3.48 GB\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003e+ Target Audience: hematologists, oncologists\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003e+ Information:\u003c\/strong\u003e\r\n\u003cdiv class=\"activitysectionbold\"\u003eDate \u0026amp; Location Friday, March 21, 2025, 7:00 AM – 6:00 PM, Leon \u0026amp; Norma Hess Center for Science and Medicine, Davis Auditorium, 1470 Madison Avenue, New York, NY\u003c\/div\u003e\r\n\u003cdiv class=\"activitysectionbold\"\u003eTarget Audience \u003cem\u003eSpecialties\u003c\/em\u003e – Academic\/Research, Genomic Medicine, Geriatric Medicine, Hematology, Internal Medicine, Multiple Specialties, Nurse Practitioner, Nursing, Oncology, Pathology, Pharmacist, Physician Assistant\u003c\/div\u003e\r\n\u003cdiv\u003e\u003c\/div\u003e\r\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eCourse Overview\u003c\/strong\u003e\u003c\/div\u003e\r\nThis workshop will include speakers with international recognition for excellence in science and clinical care of myeloid malignancies. Given the relative rarity of each disease, rapid pace of scientific discovery over the last several years, recent approval of novel agents, and the multitude of investigational agents in late-stage clinical development it is imperative to provide cutting edge updates in a focused manner. The target audience for this CME-accredited event will include clinical and laboratory-based physicians, trainees, laboratory investigators, pharmacists, nurses, nurse practitioners, physician assistants, and patients. The event would take place in a lecture hall on the campus of Mount Sinai. The talks will be 30 minutes in duration and followed by 10-minute question and answer sessions. The event will be moderated by John Mascarenhas, Marina Kremyanskaya and Ruben Mesa and the audience will be encouraged to participate in Q\u0026amp;A sessions. Additionally, there will be audience response system (ARS) questions before and after to gauge impact on learning.\r\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eObjectives\u003c\/strong\u003e\u003c\/div\u003e\r\n\u003col\u003e\r\n \t\u003cli\u003eUnderstand modern laboratory tools for exploring myeloid malignancy pathway for therapeutic targeting\u003c\/li\u003e\r\n \t\u003cli\u003eRecognize the appropriate evidence-based therapies for patients with myeloid leukemia\u003c\/li\u003e\r\n \t\u003cli\u003eUnderstand complex cellular mechanisms driving thrombosis in myeloproliferative neoplasms\u003c\/li\u003e\r\n \t\u003cli\u003eIdentify patient specific approaches and therapeutic options for patients with myelodysplastic syndromes\u003c\/li\u003e\r\n \t\u003cli\u003eDiscuss the emerging results of laboratory and clinical studies providing insights into biology and potential interventions in CHIP\/CCUS\u003c\/li\u003e\r\n \t\u003cli\u003eIdentify treatment goals for systemic mastocytosis that incorporate next generation kit inhibitors.\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\nThe Icahn School of Medicine’s Myeloid Malignancy Workshop 2025 is best for hematologists, oncologists, clinician-scientists, fellows, and researchers focused on myeloid cancers who want cutting-edge updates on diagnostics, therapeutics, and clinical trials.\r\n\u003ch3\u003e\n\u003cimg class=\"emoji\" role=\"img\" draggable=\"false\" src=\"https:\/\/s.w.org\/images\/core\/emoji\/17.0.2\/svg\/1f469-200d-2695-fe0f.svg\" alt=\"👩‍⚕️\"\u003e Who Should Attend\u003c\/h3\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003eHematologists and oncologists treating patients with AML, MDS, MPNs, and other myeloid malignancies\u003c\/li\u003e\r\n \t\u003cli\u003eFellows and residents specializing in hematology-oncology or internal medicine\u003c\/li\u003e\r\n \t\u003cli\u003eClinical researchers and translational scientists working on novel therapies and molecular targets\u003c\/li\u003e\r\n \t\u003cli\u003ePharmaceutical professionals involved in drug development for hematologic cancers\u003c\/li\u003e\r\n \t\u003cli\u003eAdvanced practice providers and oncology nurses supporting myeloid cancer care\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003e\n\u003cimg class=\"emoji\" role=\"img\" draggable=\"false\" src=\"https:\/\/s.w.org\/images\/core\/emoji\/17.0.2\/svg\/1f4da.svg\" alt=\"📚\"\u003e What You’ll Learn\u003c\/h3\u003e\r\nThis workshop delivers focused, high-level insights into the rapidly evolving landscape of myeloid malignancies. Key highlights include:\r\n\u003cul\u003e\r\n \t\u003cli\u003eUpdates on newly approved agents and investigational therapies in late-stage development\u003c\/li\u003e\r\n \t\u003cli\u003eAdvances in molecular diagnostics, risk stratification, and personalized treatment\u003c\/li\u003e\r\n \t\u003cli\u003eMultidisciplinary perspectives from internationally recognized experts in clinical care and research\u003c\/li\u003e\r\n \t\u003cli\u003eDiscussions on clinical trial design, patient selection, and outcome optimization\u003c\/li\u003e\r\n \t\u003cli\u003eNetworking opportunities with leaders in academic and industry settings\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv\u003e\u003c\/div\u003e\r\n\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\r\n\u003ch3 class=\"boxAgendaTitle\"\u003eFriday, March 21, 2025\u003c\/h3\u003e\r\n\u003cdiv class=\"row 50%\"\u003e\r\n\u003cdiv class=\"12u\"\u003e\r\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\r\n\u003cdiv class=\"row 50%\"\u003e\r\n\u003cul\u003e\r\n \t\u003cli class=\"10u\"\u003e7:45AM – 8:45AM Registration and Breakfast\u003c\/li\u003e\r\n \t\u003cli class=\"10u\"\u003e8:45AM – 9:00AM Introduction John Mascarenhas, MD Marina Kremyanskaya, MD Ruben A. Mesa, MD\u003c\/li\u003e\r\n \t\u003cli class=\"10u\"\u003e9:00AM – 9:40AM Recent Insights into Myeloid Malignancy and Clonal Hematopoiesis from Human iPSC Models Eirini Papapetrou, MD, PhD\u003c\/li\u003e\r\n \t\u003cli class=\"10u\"\u003e9:40AM – 10:20AM CHIP and CCUS Next Steps Kelly Bolton, MD\u003c\/li\u003e\r\n \t\u003cli class=\"10u\"\u003e10:20AM – 11:00AM State of the Art Management for Systemic Mastocytosis Jason Gotlib, MD, MS\u003c\/li\u003e\r\n \t\u003cli class=\"10u\"\u003e11:00AM – 11:30AM Break\u003c\/li\u003e\r\n \t\u003cli class=\"10u\"\u003e11:30AM – 12:10PM Modeling Thrombosis in MPN Joan D Beckman, MD\u003c\/li\u003e\r\n \t\u003cli class=\"10u\"\u003e12:10PM – 12:50PM Novel Approaches and Approvals in MDS Guillermo Garcia-Manero, MD\u003c\/li\u003e\r\n \t\u003cli class=\"10u\"\u003e12:50PM – 1:50PM Lunch\u003c\/li\u003e\r\n \t\u003cli class=\"10u\"\u003e1:50PM – 2:30PM Evolving Paradigm Shifts in CML Jorge Cortes, MD\u003c\/li\u003e\r\n \t\u003cli class=\"10u\"\u003e2:30PM – 3:10PM Deciphering Esoinophilia Amy Klion, MD\u003c\/li\u003e\r\n \t\u003cli class=\"10u\"\u003e3:10PM – 3:30PM Break\u003c\/li\u003e\r\n \t\u003cli class=\"10u\"\u003e3:30PM – 4:10PM Future Directions in AML Therapy Naval Daver, MD\u003c\/li\u003e\r\n \t\u003cli class=\"10u\"\u003e4:10PM – 4:50PM Insights from the Hematopathologist Daniel A. Arber, MD\u003c\/li\u003e\r\n \t\u003cli class=\"10u\"\u003e4:50PM – 5:15PM Awards Presentation and Closing Remarks John Mascarenhas, MD Marina Kremyanskaya, MD Ruben A. Mesa, MD\u003c\/li\u003e\r\n \t\u003cli class=\"10u\"\u003e5:15PM – 5:17PM Adjourn\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954519248994,"sku":"MED-AMB05176","price":20.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Icahn-School-of-Medicine-Myeloid-Malignancy-Workshop-2025_c563c19a-ed1e-4076-9712-f8381b6189a9.jpg?v=1779378745","url":"https:\/\/meducourse.com\/products\/icahn-school-of-medicine-myeloid-malignancy-workshop-2025","provider":"Meducourse","version":"1.0","type":"link"}